Business Description
DICE Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US23345J1043
Description
DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -57.4 | |||||
| 3-Year EPS without NRI Growth Rate | -56.4 | |||||
| 3-Year FCF Growth Rate | -31.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 57.27 | |||||
| 12-1 Month Momentum % | 137.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 25.88 | |||||
| Quick Ratio | 25.88 | |||||
| Cash Ratio | 25.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.1 | |||||
| Shareholder Yield % | -0.19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -24 | |||||
| ROA % | -22.58 | |||||
| ROIC % | -639.29 | |||||
| ROC (Joel Greenblatt) % | -630.15 | |||||
| ROCE % | -23.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.38 | |||||
| Price-to-Tangible-Book | 4.38 | |||||
| EV-to-EBIT | -16.94 | |||||
| EV-to-Forward-EBIT | -11.07 | |||||
| EV-to-EBITDA | -17.36 | |||||
| EV-to-FCF | -20.14 | |||||
| Price-to-Net-Current-Asset-Value | 4.54 | |||||
| Price-to-Net-Cash | 4.58 | |||||
| Earnings Yield (Greenblatt) % | -5.9 | |||||
| FCF Yield % | -4.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DICE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DICE Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.34 | ||
| Beta | 0 | ||
| Volatility % | 91.34 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.167864 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 137.94 | ||
| 52-Week Range ($) | 15.08 - 47.9 | ||
| Shares Outstanding (Mil) | 47.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DICE Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DICE Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DICE Therapeutics Inc Frequently Asked Questions
What is DICE Therapeutics Inc(DICE)'s stock price today?
The current price of DICE is $47.55. The 52 week high of DICE is $47.90 and 52 week low is $15.08.
When is next earnings date of DICE Therapeutics Inc(DICE)?
The next earnings date of DICE Therapeutics Inc(DICE) is 2025-03-15 Est..
Does DICE Therapeutics Inc(DICE) pay dividends? If so, how much?
DICE Therapeutics Inc(DICE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers